130 related articles for article (PubMed ID: 9177835)
1. 99mTc-labeled sigma-receptor-binding complex: synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells.
John CS; Lim BB; Geyer BC; Vilner BJ; Bowen WD
Bioconjug Chem; 1997; 8(3):304-9. PubMed ID: 9177835
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.
John CS; Bowen WD; Fisher SJ; Lim BB; Geyer BC; Vilner BJ; Wahl RL
Nucl Med Biol; 1999 May; 26(4):377-82. PubMed ID: 10382840
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.
John CS; Vilner BJ; Gulden ME; Efange SM; Langason RB; Moody TW; Bowen WD
Cancer Res; 1995 Jul; 55(14):3022-7. PubMed ID: 7606722
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors.
John CS; Gulden ME; Vilner BJ; Bowen WD
Nucl Med Biol; 1996 Aug; 23(6):761-6. PubMed ID: 8940718
[TBL] [Abstract][Full Text] [Related]
5. Substituted halogenated arylsulfonamides: a new class of sigma receptor binding tumor imaging agents.
John CS; Lim BB; Vilner BJ; Geyer BC; Bowen WD
J Med Chem; 1998 Jul; 41(14):2445-50. PubMed ID: 9651150
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
John CS; Gulden ME; Li J; Bowen WD; McAfee JG; Thakur ML
Nucl Med Biol; 1998 Apr; 25(3):189-94. PubMed ID: 9620622
[TBL] [Abstract][Full Text] [Related]
7. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Vilner BJ; John CS; Bowen WD
Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
[TBL] [Abstract][Full Text] [Related]
8. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
John CS; Vilner BJ; Geyer BC; Moody T; Bowen WD
Cancer Res; 1999 Sep; 59(18):4578-83. PubMed ID: 10493511
[TBL] [Abstract][Full Text] [Related]
9. Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent.
Choi SR; Yang B; Plössl K; Chumpradit S; Wey SP; Acton PD; Wheeler K; Mach RH; Kung HF
Nucl Med Biol; 2001 Aug; 28(6):657-66. PubMed ID: 11518647
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of a novel 99mTc cyclopentadienyl tricarbonyl complex ([(Cp-R)99mTc(CO)3]) for sigma-2 receptor tumor imaging.
Chen X; Cui MC; Deuther-Conrad W; Tu YF; Ma T; Xie Y; Jia B; Li Y; Xie F; Wang X; Steinbach J; Brust P; Liu BL; Jia HM
Bioorg Med Chem Lett; 2012 Oct; 22(20):6352-7. PubMed ID: 22995625
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo characterisation of [3H]ANSTO-14 binding to the sigma 1 binding sites.
Nguyen VH; Mardon K; Kassiou M; Christie MD
Nucl Med Biol; 1999 Feb; 26(2):209-15. PubMed ID: 10100221
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker.
Hou C; Tu Z; Mach R; Kung HF; Kung MP
Nucl Med Biol; 2006 Feb; 33(2):203-9. PubMed ID: 16546674
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides.
Vallabhajosula S; Moyer BR; Lister-James J; McBride BJ; Lipszyc H; Lee H; Bastidas D; Dean RT
J Nucl Med; 1996 Jun; 37(6):1016-22. PubMed ID: 8683294
[TBL] [Abstract][Full Text] [Related]
14. [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
Bonhaus DW; Loury DN; Jakeman LB; To Z; DeSouza A; Eglen RM; Wong EH
J Pharmacol Exp Ther; 1993 Nov; 267(2):961-70. PubMed ID: 8246171
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro evaluation of iodinated derivatives of piperazine as a new ligand for sigma receptor imaging by single photon emission computed tomography.
Hirata M; Mori T; Soga S; Umeda T; Ohmomo Y
Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):470-5. PubMed ID: 16595947
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of binding of [3H]NE-100, a novel sigma-receptor ligand, to guinea-pig brain membranes.
Tanaka M; Shirasaki T; Kaku S; Muramatsu M; Otomo S
Naunyn Schmiedebergs Arch Pharmacol; 1995 Mar; 351(3):244-51. PubMed ID: 7609777
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of [18F] labeled benzamides: high affinity sigma receptor ligands for PET imaging.
Dence CS; John CS; Bowen WD; Welch MJ
Nucl Med Biol; 1997 May; 24(4):333-40. PubMed ID: 9257332
[TBL] [Abstract][Full Text] [Related]
19. N-(N-benzylpiperidin-4-yl)-2-[18F]fluorobenzamide: a potential ligand for PET imaging of sigma receptors.
Shiue CY; Shiue GG; Zhang SX; Wilder S; Greenberg JH; Benard F; Wortman JA; Alavi AA
Nucl Med Biol; 1997 Oct; 24(7):671-6. PubMed ID: 9352539
[TBL] [Abstract][Full Text] [Related]
20. N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice.
Matsumoto RR; McCracken KA; Pouw B; Miller J; Bowen WD; Williams W; De Costa BR
Eur J Pharmacol; 2001 Jan; 411(3):261-73. PubMed ID: 11164383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
